Freitag, 6. August 2021
Navigation öffnen

Influence of the "Hypotension Probability Index" on Intraoperative and Postoperative Hypotension in ENT- and OM-Surgery

Noch nicht rekrutierend


Oktober 2019

Letztes Update:


Indikation (Clinical Trials):
Acute Kidney Injury, Hypotension, Otorhinolaryngologic Diseases


Erwachsene (18+)


University of Giessen, University of Giessen

Edwards Lifesciences, Edwards Lifesciences


Michael Sander, Prof.
Study Director
UKGM Giessen


Michael Sander, Prof.
Phone: 004964198544401
» Kontaktdaten anzeigen

(1 von 1)

University Clinic Giessen
35392 Gießen
GermanyNoch nicht rekrutierend» Google-Maps
Michael Sander, Prof.
Phone: 004964198544401
» Ansprechpartner anzeigen


Detailed Description:

Blood pressure monitoring displays a crucial part of anesthetic management. An intraoperative hypotension (IOH) is an unwanted complication that can occur during an anaesthetization or during the following duration of the surgery. Causes for this can be vasodilatation (e.g. due to medication), loss of blood volume (e.g. bleeding) or lack of inotropy (reduced left ventricular function, e.g. due to medication).

The main high-risk factors for intraoperative hypotension are age of the patient, pre-existing diseases (especially ASA 3 and higher), the duration of surgery, the urgency of the surgery (emergency surgery), antihypertensive long-term medication as well as combined anaesthesia (regional and general anaesthesia).

According to the examined collective, the definition of IOH and the level of training of the performing doctor we can monitor IOH in up to 100% of patients (depending on the data collection). Monk et al. show that the one-year mortality of patients undergoing surgery was elevated to 3.6% for every minute the systolic pressure was less than 80mmHg. Also, the risk of mortality was 1.4 higher if the MAP decreased <55mmHg. The consequence of IOH can be a critical reduction of the oxygen supply in the organs. Therefore, organs with low tolerance for hypoxia or a high necessity for oxygen are prone to hypotension induced complications. Those include ischemic stroke or myocardial ischemia (especially in patients with preexisting anemia), mostly happening to older or critical ill patients.

The extensive surgeries in ENT- and OM surgery are usually due to tumor diseases. The incidence for hypopharynx carcinoma is between 2-3/10.000 cases each year with an increasing tendency. The peak of this disease is in the 5.-6. decade of life. Causes for this are chronic noxas like alcohol and cigarettes. Numbers show, that the percentage of malignant tumors in the oral cavity and the pharynx in Germany in 2012 were at 3.7% with men and 1.6% with women in the entirety of incidence of malignant tumors. Especially these tumors require a radical resection also in the initial state of the disease which comes along with a long duration of surgery. The operative interventions include a radical resection of the tumor, neck dissection and if necessary a skin flap depending on the state of the tumor, TNM classification and status of lymph nodes. Complications that can occur with these types of surgery are (secondary) bleeding, stenosis, dyspnea, oedema of the mucosa, subcutaneous emphysema, dysphagia and aspiration. Because of the surgical treatment these patients require a postoperative sedation and ventilation. This enables the protection of the respiratory system when patients are at high risk for intra- or postoperative secondary bleeding and/or swelling. Also, the sedation will help not to imperil the success of the intervention (e.g. through coughing, pressure or choking).

The Hypotension Prediction Index (HPI) was developed by Edwards Lifescience (Irvine, California, USA) and is certified in the US and Europe. As part of the Edwards Acumen Decision Support software suite, the HPI is based on the minimal invasive FloTrac IQ sensor. The HPI indicates the probability of an occurring hypotensive event. The software was developed using 20,000 cases of past patient events. If the upper limit of hypotension is reached, the software will alert the responsible physician.

The main outcome criteria are the numbers (n) and duration in minutes (t [min]) of intraoperative and postoperative hypotension. These are defined as MAP below 65 mmHg for more than one minute in ventilated patients with and without the use of HPI.

The secondary objective criteria are the following:

- Assumed reason for hypotension

- Amount of applied infusion volume (crystalloids, colloids, blood products and blood)

- Type and dose of applied vasopressors

- Type and dose of applied inotropic agents

- Acute Kidney Injury Risk Score


Inclusion Criteria:

- extensive surgery in the head and neck area

- Age ≥ 18 years

Exclusion Criteria:

- Participation in another interventional study

- Pregnancy and nursing mothers

- Surgery without controlled ventilation

- Contraindication to invasive arterial pressure measurement

- Renal insufficiency KDIGO stage ≥ 3

- Congenital coagulation disorder


Primary outcome:

1. number (n) of intraoperative and postoperative hypotension (Time Frame - until 4 hours after the end of surgery):
MAP below 65 mmHg for more than one minute in ventilated patients

Secondary outcome:

1. Applied volume in ml (Time Frame - until 4 hours after the end of surgery):
Amount of applied infusion volume (crystalloids, colloids, blood products and blood) in ml

2. Changes of catecholamine management (Time Frame - until 4 hours after the end of surgery):
Dosage of vasopressors and inotropes (in μg)

3. Duration of surgery (Time Frame - up to 24 hours):
cut-seam time

4. Fluid balance (Time Frame - until 4 hours after the end of surgery):
blood loss and urin output in ml

5. Hospital length of stay (Time Frame - up to 18 month):
Duration of stay in hospital


  • No Intervention: Control Arm
    blinded HPI monitoring
  • Active Comparator: Intervention Arm
    HPI monitoring to predict hypotension

Geprüfte Regime

  • Hypotension probability index (HPI):
    The intervention group is managed with the HPI parameter to detect and possibly prevent hypotension during anaesthesia.


Das könnte Sie auch interessieren
EHA 2021
  • SCD: Häufigere und längere VOC-bedingte Krankenhausaufenthalte nach Vorgeschichte von VOC-Hospitalisierungen – Ergebnisse einer Beobachtungsstudie
  • Real-World-Daten des ERNEST-Registers untermauern Überlebensvorteil unter Ruxolitinib bei primärer und sekundärer Myelofibrose
  • I-WISh-Studie: Ärzte sehen TPO-RAs als beste Option, um anhaltende Remissionen bei ITP-Patienten zu erzielen
  • Phase-III-Studie REACH2 bei steroidrefraktärer akuter GvHD: Hohes Ansprechen auf Ruxolitinib auch nach Crossover
  • SCD: Neues digitales Schmerztagebuch zur tagesaktuellen Erfassung von VOCs wird in Beobachtungsstudie geprüft
  • Französische Real-World-Studie: Eltrombopag meist frühzeitig nach ITP-Diagnose im Rahmen eines Off-label-Use eingesetzt
  • Fortgeschrittene systemische Mastozytose: Französische Real-World-Studie bestätigt klinische Studiendaten zur Wirksamkeit von Midostaurin
  • CML-Management weitgehend leitliniengerecht, aber verbesserungsfähig – Ergebnisse einer Querschnittsbefragung bei britischen Hämatologen
  • Britische Real-World-Studie: Kardiovaskuläres Risikomanagement bei MPN-Patienten in der Primärversorgung nicht optimal
  • Myelofibrose: Früher Einsatz von Ruxolitinib unabhängig vom Ausmaß der Knochenmarkfibrose